Study |
n |
Paroxysmal AF |
Acute PV
isolation |
Ablation Time, min |
Procedure time,
min |
Fluoroscopy
time, min |
PN
palsy |
Other adverse
events |
Freedom from AF during
long-term follow-up |
Linhart, et al.[68]
RF
Cryoballoon |
20
20 |
20 (100%)
20 (100%) |
100%
81% |
N/A
N/A |
200 ± 67
166 ± 39 |
55 ± 23
41 ± 13 |
0%
15% |
0%
0% |
45% at 6 months
50% at 6 months |
Kojodjojo, et al.[69]
RF
Cryoballoon |
53
90 |
53 (100%)
90 (100%) |
99%
83% |
N/A
N/A |
208 ± 58
108 ± 28 |
62 ± 36
27 ± 9 |
0%
2.2% |
3.8%
1.1% |
72% at 1 year
77% at 1 year |
Tayebjee, et al.[70]
RF
Cryoballoon |
25
25 |
25 (100%)
25 (100%) |
100%
76% |
N/A
N/A |
35
45 |
0%
8% |
0%
4% |
4%
4% |
52% at 1 year
56% at 1 year |
Kühne, et al.[71]
RF
Cryoballoon |
25
25 |
25 (100%)
25 (100%) |
00%
100% |
47
45 |
197 ± 52
166 ± 32 |
46 ± 22
61 ± 25 |
0%
4% |
4%
4% |
92% at 1 year
88% at 1 year |
Sorgente, et al.[72]
RF
Cryoballoon |
29
30 |
20 (69%)
24 (80%) |
100%
100% |
N/A
N/A |
N/A
N/A |
N/A
N/A |
0%
10% |
13.8%
3.3% |
66% at 1 year
66% at 1 year |
Herrera Siklódy, et al.[73]
RF
Cryoballoon |
30
30 |
17 (57%)
21 (70%) |
100%
100% |
52 ± 21
44 ±6 |
200 ± 46
177 ± 30 |
37 ± 16
38 ± 12 |
0%
6.7% |
0%
6.7% |
80% at 1 year
63% at 1 year |
Schmidt, et al.[74]
RF
Cryoballoon |
2,870
905 |
2,870 (100%)
905 (100%) |
98%
97% |
33
45 |
165
160 |
24
34 |
0%
2.1% |
4.6%
2.7% |
N/A
N/A |
Mugnai, et al.[75]
RF
Cryoballoon |
260
136 |
260 (100%)
136 (100%) |
100%
100% |
43 ± 6
45 ± 4 |
192 ± 49
112 ± 58 |
36 ± 14
31 ± 17 |
0%
8.1% |
14.2%
11.0% |
57% at 23 months
63% at 23 months |
Juliá, et al.[76]
RF†
Cryoballoon* |
186
100 |
186 (100%)
100 (100%) |
98%
100% |
N/A
N/A |
190 ± 57
117 ± 59 |
35 ± 19
27 ± 16 |
N/A
N/A |
N/A
N/A |
80% at 1 year
81% at 1 year |
Aryana, et al.[58]
RF
Cryoballoon** |
422
633 |
319 (76%)
472 (75%) |
99%
98% |
66 ± 26
40 ± 14 |
188 ± 42
145 ± 49 |
23 ± 14
29 ± 1 |
0%
7.6% |
2.6%
1.6% |
60% at 1 year
77% at 1 year |
Jourda, et al.[79]
RF†
Cryoballoon** |
75
75 |
75 (100%)
75 (100%) |
100%
100% |
2 ± 13
32 ± 3 |
111 ± 32
134 ± 48 |
21 ± 8
25 ± 10 |
0%
17.3% |
2.7%
1.3% |
88% at 1 year
85% at 1 year |